Research Information System
Seminars in Nuclear Medicine, vol.56, no.2, pp.278-288, 2026 (SCI-Expanded, Scopus)
Dynamic renal scintigraphy (DRS) has been in routine practice since late 70’s and it shows kidney perfusion, concentration function and allows the evaluation of excretion function. The radiopharmaceuticals used for this procedure are excreted either via glomerular filtration or by tubular extraction. Either way DRS allows the nuclear medicine physician to quantify renal functions. There are many parameters introduced for clinical practice and described in detail in nuclear medicine guidelines. This paper aims to recall and underline the importance of these parameters and use of these parameters in advancing clinical research. Nuclear medicine has been working in close relation with basic research, its close collaboration with radiopharmacy provides development of new radiopharmaceuticals for kidney imaging, in addition, technological and software innovation enables us to perform faster acquisitions with lower doses and enables better resolution images. Still, processing and quantification in renal analysis is complicated for average nuclear medicine physicians. Recent advances in artificial intelligence have the potential to overcome this problem. With the help of such algorithms renal scintigraphies have the potential to enlighten clinical problems.